United Health Products Stock price
$0.04
+0.01
18.75%
1M
-0.03
43.79%
6M
-0.02
30.40%
YTD
-0.03
40.63%
1Y
-0.22
85.38%
3Y
-0.84
95.68%
5Y
-0.05
55.29%
10Y
-0.46
92.40%
20Y
Nasdaq,
Closing price Thu, Nov 05 2026
+0.01
18.75%
Powered by
ISIN
US91059D1000
Symbol
UEEC
Industry
Is United Health Products a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.
Key metrics
Basic
Market capitalization
$13.1m
Enterprise Value
$15.4m
Net debt
$2.3m
Cash
$20.0k
Shares outstanding
261.6m
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
negative | -
P/B
negative
Financial Health
Equity Ratio
-1,224.0%
Return on Equity
68.9%
ROCE
29.8%
ROIC
-
Debt/Equity
-0.5
United Health Products Events
Upcoming Event
Don't miss a Thing! We will send you all news about United Health Products directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. It also offers HemoStyp to control bleeding. The company was founded on February 28, 1997 and is headquartered in Mount Laurel, NJ.
| Head office | United States |
| CEO | Mr. Thom |
| Employees | 4 |
| Founded | 1997 |
| Website | uhpcorp.com |


